In recent months, there have been numerous reports by health care experts and security individuals on the risks of importing prescription drugs. The Pharmaceutical Research and Manufacturers of America (PhRMA) is taking action with an online clearinghouse so patients and consumers can learn firsthand about experts' opinions on the dangers associated with importing medicines.
The Web site (www.buysafedrugs. info) provides information on safe, legal ways patients can save money on prescription drugs, educates patients on the risks of importing medicines, and why legalizing importation is a bad policy. "This site will help people understand the wide scope and depth of information that demonstrates [how] importing prescription drugs outside of the FDA delivery system puts patients at risk. It also points patients to safe, legal alternatives to importation if they need help with their prescription drugs," said Billy Tauzin, president and chief executive officer of PhRMA.
To that end, PhRMA formed the Partnership for Prescription Assistance, which offers a single point of access to >275 public and private assistance programs, including >150 programs offered by pharmaceutical companies. For more information, visit www.pparx.org, or call 888-4PPANOW (888-477-2669).
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs